

Founded in 2017
Section 32 focus areas include biotechnology, therapeutics, advanced diagnostics, precision medicine, software, cybersecurity, machine learning, and artificial intelligence. The firm’s goal is to improve the human condition by accelerating the discovery, development, adoption and distribution of imp...